Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy

PURPOSE: Glioma is the most prevalent malignant form of brain tumors, with a dismal prognosis. Currently, cancer immunotherapy has emerged as a revolutionary treatment for patients with advanced highly aggressive therapy-resistant tumors. However, there is no effective biomarker to reflect the respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Houshi, Zhu, Qingwei, Tang, Lan, Jiang, Junkun, Yuan, Huiwen, Zhang, Anke, Lou, Meiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881595/
https://www.ncbi.nlm.nih.gov/pubmed/33579299
http://dx.doi.org/10.1186/s12935-021-01804-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881595/
https://www.ncbi.nlm.nih.gov/pubmed/33579299
http://dx.doi.org/10.1186/s12935-021-01804-3

Ejemplares similares